New neurosurgery chair, Maciej S. Lesniak, MD, MHCM, combats brain cancer with a multifaceted biological approach.
Northwestern Medicine scientists discovered that nitric oxide is part of a new form of cell learning in the striatum, the region of the brain involved in the symptoms of Parkinson’s disease and schizophrenia.
A brain region controlling whether we feel happy or sad, as well as addiction, is remodeled by chronic pain, according to a new Northwestern Medicine study, and a new treatment targeting this region may dramatically lessen symptoms.
The Fall and Winter issue of Northwestern Research Magazine, which highlights the discoveries of Northwestern scholars, focuses on interdisciplinary cognitive science, including several Feinberg scientists.
A specially developed nanoparticle may be able to prevent progression of multiple sclerosis triggered by the death of brain cells that make the insulation around nerve fibers.
The Fifth Annual Les Turner Symposium on ALS and NeuroRepair celebrated a new research and clinical care center and featured a variety of presentations, a keynote lecture and a poster session.
Northwestern Medicine scientists have identified a novel strategy for reducing the side effects of the drug levodopa, which is commonly used to treat the stiffness, tremors and poor muscle control of Parkinson’s disease.
Northwestern scientists have developed a microfluidic device to sort neural stem cell populations, making them easier to study, a tool may lead to a better understanding of how stem cells function.
SchizConnect, the first neuroimaging meta-database dedicated to clinical schizophrenia research, will allow scientists to see broader results across many more subjects than ever before.
Northwestern Medicine scientists pinpointed a master switch that orchestrates thousands of genetic pathways an internal body clock takes to dictate how and when our pancreas must produce insulin and control blood sugar.